1. Zheng Y, Ley SH, Hu FB. Global aetiologyandepidemiology oftype 2 diabetes mellitus and its complications. Nat Rev Endocrinol.2018;14(2):88-98.
2. Holman N, Young B, Gadsby R. Current prevalence of type 1 and type 2diabetes in adults and children in the UK. Diabet Med. 2015;32(9):1119-1120.
3. Bruno G,Runzo C, Cavallo-Perin P, et al; Piedmont Study Group forDiabetes Epidemiology. Incidence of type 1 and type 2 diabetes inadults aged 30-49 years: the population-based registry in the provinceof Turin, Italy.Diabetes Care. 2005;28(11):2613-2619.
4. Tinajero MG, Malik VS. An update on the epidemiology of type 2diabetes: a global perspective. Endocrinol Metab Clin North Am.2021;50(3):337-355.
5. Russell JW, Zilliox LA. Diabetic neuropathies.Continuum: lifelong learning in neurology. Peripheral Nervous System Disorders.2014;20(5):1226-1240.
6. Ziegler D, Keller J, Maier C, Pannek J.Diabetic Neuropathy. Exp ClinEndocrinol Diabetes. 2023;131(1-02):72-83.
7. Brown MJ,Asbury AK. Diabetic neuropathy.AnnNeurol.1984;15(1):2-12.
8. Zochodne DW. Diabetic neuropathies: features and mechanisms.BrainPathol.1999;9(2):369-391.
9. Pop-Busui R,Boulton AJM,Feldman EL,et al. Diagnosis and treatmentof painful diabetic neuropathy.ADA Clin Compend Ser.2022;2022:1-32.
10. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severityof various types of diabetic neuropathy, retinopathy, andnephropathyin a population-based cohort: the Rochester Diabetic NeuropathyStudy. Neurology. 1993;43(4):817-824.
11. Llewelyn JG, Tomlinson DR, Thomas PK. Diabetic neuropathies.InPeripheral Neuropathy. 4th ed. Dyck PJ, Thomas PK, Eds.Philadelphia, Elsevier. 2005, p. 1951-1992.
12. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ 3rd, O’BrienPC. Risk factors for severity of diabetic polyneuropathy: intensive longattitudinal assessment of the Rochester Diabetic Neuropathy Studycohort. Diabetes Care. 1999;22(9):1479-1486.
13. Tesfaye S, Chaturvedi N, Eaton SE, et al; EURODIAB ProspectiveComplications Study Group. Vascular risk factors and diabeticneuropathy. N Engl J Med. 2005;352(4):341-350.
14. Dyck PJ, Davies JL, Clark VM, et al.Modeling chronic glycemicexposure variables as correlates and predictors of microvascularcomplications of diabetes. Diabetes Care. 2006;29(10):2282-2288.
15. Thomas PK. Classification, differential diagnosis and staging of diabeticperipheral neuropathy. Diabetes. 1997;46(Suppl.2):S54-S57.
16. Boulton AJ, Vinik AI, Arezzo JC, et al;American Diabetes Association.Diabetic neuropathies: a statement by the American DiabetesAssociation. Diabetes Care. 2005;28(4):956-962.
17. Archer AG, Watkins PJ, Thomas PK, Sharma AK, Payan J. The naturalhistory of acute painful neuropathy in diabetes mellitus. J NeurolNeurosurg Psychiatry. 1983;46(6):491-499.
18. Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update ondefinitions, diagnosticcriteria, estimation of severity, and treatments.Diabetes Care. 2010;33(10):2285-2293.
19. Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy.Nat Rev Dis Primers. 2019;5(1):41.
20. Albers JW, Pop-Busui R. Diabetic neuropathy: mechanisms, emergingtreatments, and subtypes. Curr Neurol Neurosci Rep. 2014;14(8):473.
21. Callaghan BC, Kerber KA, Lisabeth LL, et al. Role of neurologistsand diagnostic tests on the management of distal symmetric polyneuropathy. JAMA Neurol. 2014;71(9):1143-1149.
22. Dyck PJ, Albers JW, Andersen H, et al. Toronto Expert Panel onDiabetic Neuropathy. Diabetic polyneuropathies: update on researchdefinition, diagnostic criteria and estimation of severity. DiabetesMetab Res Rev. 2011;27(7):620-628.
23. Malik RA, Veves A, Tesfaye S, et al. Toronto Consensus Panel onDiabetic Neuropathy. Small fibre neuropathy: role in the diagnosisof diabetic sensorimotor polyneuropathy. Diabetes Metab Res Rev.2011;27(7):678-684.
24. Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: aposition statement by the American Diabetes Association. DiabetesCare. 2017;40(1):136-154.
25. Feldman EL.Pathogenesis of diabetic polyneuropathy. [UpToDate]
26. Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabeticneuropathy: Where are wenow and where to go? J DiabetesInvestig.2011;2(1):18-32.
27. Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinicalmanagement of diabetic sensorimotor peripheral neuropathy. Nat RevEndocrinol. 2021;17(7):400- 420
28. Feldman EL. Screening for diabetic polyneuropathy. [UpToDate]
29. American Diabetes Association Professional Practice Committee; 12.Retinopathy, Neuropathy, and Foot Care: Standards of MedicalCare inDiabetes-2022. Diabetes Care. 2022;45(Suppl 1):S185-S194.
30. Kaku M, Vinik A, Simpson DM. Pathways in the diagnosis andmanagement of diabetic polyneuropathy. Curr Diab Rep. 2015;15(6):609
31. Feldman EL. Management of diabetic neuropathy. [UpToDate]
32. Khdour MR. Treatment of diabetic peripheralneuropathy: a review. JPharm Pharmacol. 2020;72(7):863-872